Arcus Biosciences (RCUS) Earnings Date, Estimates & Call Transcripts $10.53 -0.36 (-3.31%) Closing price 03:59 PM EasternExtended Trading$10.86 +0.33 (+3.09%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Arcus Biosciences Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 14After Market ClosesEstimatedActual EPS (Feb. 25) -$1.03 Beat By $0.14 Consensus EPS (Feb. 25) -$1.17 Arcus Biosciences posted Q4 2024 earnings on February 25, 2025, reporting an EPS of -$1.03, which beat the consensus estimate of -$1.17 by $0.14. Quarterly revenue was reported to be $36 million, above the consensus estimate of $29.38 million. With a trailing EPS of -$3.10, Arcus Biosciences' earnings are expected to decrease next year, from ($3.15) to ($4.73) per share. RCUS Upcoming EarningsArcus Biosciences' next earnings date is estimated for Wednesday, May 14, 2025, based off prior year's reporting schedules. Get Arcus Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcus Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRCUS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RCUS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Arcus Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$1.13-$1.08-$1.11Q2 20253-$1.11-$0.93-$1.02Q3 20253-$1.09-$0.97-$1.03Q4 20253-$1.08-$0.96-$1.03FY 202512-$4.41-$3.94-$4.19Q1 20261-$0.55-$0.55-$0.55Q2 20261-$1.05-$1.05-$1.05Q3 20261-$1.06-$1.06-$1.06Q4 20261-$0.11-$0.11-$0.11FY 20264($2.77)($2.77)($2.77) Arcus Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/14/2025(Estimated)-------2/25/2025Q4 2024-$1.17-$1.03+$0.14-$1.03$29.38M$36.00M11/6/2024Q3 2024-$1.06-$1.00+$0.06-$1.00$38.95M$48.00M8/8/2024Q2 2024-$1.02-$1.02--$1.02$26.24M$39.00M5/8/2024Q1 2024-$0.97-$0.05+$0.92-$0.05$28.77M$145.00M2/21/2024Q4 2023-$1.09-$1.08+$0.01-$1.08$28.30M$31.00M11/7/2023Q3 2023-$1.12-$0.94+$0.18-$0.94$27.57M$32.00M8/7/2023Q2 2023-$1.10-$1.04+$0.06-$1.04$31.81M$29.00M5/9/2023Q1 2023-$1.06-$1.09 -$0.03-$1.09$22.47M$25.00M Arcus Biosciences Earnings - Frequently Asked Questions When is Arcus Biosciences's earnings date? Arcus Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 14th, 2025 based off last year's report dates. Learn more on RCUS's earnings history. Did Arcus Biosciences beat their earnings estimates last quarter? In the previous quarter, Arcus Biosciences (NYSE:RCUS) reported ($1.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.17) by $0.14. Learn more on analysts' earnings estimate vs. RCUS's actual earnings. How much revenue does Arcus Biosciences generate each year? Arcus Biosciences (NYSE:RCUS) has a recorded annual revenue of $258 million. How much profit does Arcus Biosciences generate each year? Arcus Biosciences (NYSE:RCUS) has a recorded net income of -$307 million. RCUS has generated -$3.10 earnings per share over the last four quarters. What is Arcus Biosciences's EPS forecast for next year? Arcus Biosciences's earnings are expected to decrease from ($3.15) per share to ($4.73) per share in the next year. More Earnings Resources from MarketBeat Related Companies ADMA Earnings Date RNA Earnings Date ZLAB Earnings Date BHVN Earnings Date ALVO Earnings Date RXRX Earnings Date SRRK Earnings Date IMVT Earnings Date AKRO Earnings Date APLS Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? This page (NYSE:RCUS) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCUS Stock Alerts